Literature DB >> 6477000

Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome.

N D Vaziri, P Paule, J Toohey, E Hung, S Alikhani, R Darwish, M V Pahl.   

Abstract

The published data concerning changes of antithrombin III (ATIII) in nephrotic syndrome (NS) are contradictory. While increased ATIII activity has been reported by some investigators, decreased concentration has been shown by others and normal values by yet another group of authors. We determined plasma and urine concentrations of ATIII in a group of 20 patients with NS using an immunologic assay. In addition, plasma ATIII activity was determined. The results were compared with those obtained in a group of normal volunteers. Plasma concentration and activity of ATIII were both greatly reduced in the patients with NS. In addition, substantial quantities of ATIII were recovered in the urine of all tested patients. The present study, therefore, substantiates the low plasma concentrations of ATIII and its urinary losses in NS. In addition, a parallel reduction in plasma ATIII activity is demonstrated providing functional evidence of acquired ATIII deficiency in this condition.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477000

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  17 in total

Review 1.  Acute arterial thrombosis with antithrombin III deficiency in nephrotic syndrome: report of a case.

Authors:  M Nishimura; J Shimada; K Ito; H Kawachi; K Nishiyama
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  Protein C and anti-thrombin III levels in nephrotic syndrome and amyloidosis.

Authors:  R Topaloğlu; U Saatçi; A Bakkaloğlu; N Beşbaş; Y Başsoy
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

3.  Recurrent renal vein thrombosis and renal failure associated with antithrombin-III deficiency.

Authors:  D Ellis
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

4.  Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates.

Authors:  Giancarlo Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

Review 5.  Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms.

Authors:  Keattiyoat Wattanakit; Mary Cushman
Journal:  Curr Opin Pulm Med       Date:  2009-09       Impact factor: 3.155

6.  Evolving presentation of leg cramps in a child with nephrotic syndrome: Answers.

Authors:  Amirtha V Chinnadurai; Olivera Marsenic
Journal:  Pediatr Nephrol       Date:  2017-02-23       Impact factor: 3.714

7.  Haemostatic parameters in childhood nephrotic syndrome. (Is there any difference in protein C levels between steroid sensitive and resistant groups?)

Authors:  F Yalçinkaya; N Tümer; A N Gorgani; M Ekim; N Cakar
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

8.  Acquired factor XI deficiency in a child with membranoproliferative glomerulonephritis.

Authors:  Meghann Pine McManus; Christopher Frantz; David Gailani
Journal:  Pediatr Blood Cancer       Date:  2011-08-17       Impact factor: 3.167

9.  Hypercoagulability risk factors in children with minimal change disease and the protective role of protein-C activity.

Authors:  Neşe Ozkayin; Sevgi Mir; Kaan Kavakli
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 10.  Arterial thrombosis in the nephrotic syndrome.

Authors:  I H Fahal; P McClelland; C R Hay; G M Bell
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.